Alpha Teknova (NASDAQ:TKNO - Get Free Report) issued its earnings results on Tuesday. The company reported ($0.11) earnings per share for the quarter, Zacks reports. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. The business had revenue of $9.27 million during the quarter, compared to analysts' expectations of $9.10 million. Alpha Teknova updated its FY 2025 guidance to EPS.
Alpha Teknova Stock Performance
Shares of NASDAQ:TKNO traded up $0.36 during trading on Friday, hitting $6.09. The company's stock had a trading volume of 409,104 shares, compared to its average volume of 291,360. The company has a 50-day moving average of $8.15 and a 200-day moving average of $6.88. Alpha Teknova has a 12 month low of $1.16 and a 12 month high of $10.37. The company has a debt-to-equity ratio of 0.12, a current ratio of 4.73 and a quick ratio of 3.94. The firm has a market cap of $324.65 million, a price-to-earnings ratio of -8.23 and a beta of 0.41.
Wall Street Analyst Weigh In
Separately, Craig Hallum assumed coverage on Alpha Teknova in a research report on Monday, February 10th. They issued a "buy" rating and a $12.00 target price for the company.
View Our Latest Research Report on TKNO
About Alpha Teknova
(
Get Free Report)
Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
Read More
Before you consider Alpha Teknova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alpha Teknova wasn't on the list.
While Alpha Teknova currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
